-
1
-
-
34249711964
-
Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARα and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States
-
DOI 10.1016/j.cmet.2007.05.002, PII S1550413107001295
-
Badman MK, Pissios P, Kennedy AR, et al. (2007) Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5, 426-437. (Pubitemid 46825495)
-
(2007)
Cell Metabolism
, vol.5
, Issue.6
, pp. 426-437
-
-
Badman, M.K.1
Pissios, P.2
Kennedy, A.R.3
Koukos, G.4
Flier, J.S.5
Maratos-Flier, E.6
-
2
-
-
53949110053
-
Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver
-
Oishi K, Uchida D & Ishida N (2008) Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver. FEBS Lett 582, 3639-3642.
-
(2008)
FEBS Lett.
, vol.582
, pp. 3639-3642
-
-
Oishi, K.1
Uchida, D.2
Ishida, N.3
-
3
-
-
34447265235
-
PPARα is a key regulator of hepatic FGF21
-
DOI 10.1016/j.bbrc.2007.06.068, PII S0006291X07013083
-
Lundasen T, Hunt MC, Nilsson LM, et al. (2007) PPARalpha is a key regulator of hepatic FGF21. Biochem Biophys Res Commun 360, 437-440. (Pubitemid 47039157)
-
(2007)
Biochemical and Biophysical Research Communications
, vol.360
, Issue.2
, pp. 437-440
-
-
Lundasen, T.1
Hunt, M.C.2
Nilsson, L.-M.3
Sanyal, S.4
Angelin, B.5
Alexson, S.E.H.6
Rudling, M.7
-
4
-
-
20444435873
-
FGF-21 as a novel metabolic regulator
-
DOI 10.1172/JCI23606
-
Kharitonenkov A, Shiyanova TL, Koester A, et al. (2005) FGF-21 as a novel metabolic regulator. J Clin Invest 115, 1627-1635. (Pubitemid 40814671)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.6
, pp. 1627-1635
-
-
Kharitonenkov, A.1
Shiyanova, T.L.2
Koester, A.3
Ford, A.M.4
Micanovic, R.5
Galbreath, E.J.6
Sandusky, G.E.7
Hammond, L.J.8
Moyers, J.S.9
Owens, R.A.10
Gromada, J.11
Brozinick, J.T.12
Hawkins, E.D.13
Wroblewski, V.J.14
Li, D.-S.15
Mehrbod, F.16
Jaskunas, S.R.17
Shanafelt, A.B.18
-
5
-
-
57349098220
-
Fibroblast growth factor 21 corrects obesity in mice
-
Coskun T, Bina HA, Schneider MA, et al. (2008) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149, 6018-6027.
-
(2008)
Endocrinology
, vol.149
, pp. 6018-6027
-
-
Coskun, T.1
Bina, H.A.2
Schneider, M.A.3
-
6
-
-
61649127208
-
Fibroblast growth factor 21 reverses hepatic steatosis increases energy expenditure and improves insulin sensitivity in diet-induced obese mice
-
Xu J, Lloyd DJ, Hale C, et al. (2009) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250-259.
-
(2009)
Diabetes
, vol.58
, pp. 250-259
-
-
Xu, J.1
Lloyd, D.J.2
Hale, C.3
-
7
-
-
0034964992
-
The biologically active isomers of conjugated linoleic acid
-
DOI 10.1016/S0163-7827(01)00008-X, PII S016378270100008X
-
Pariza MW, Park Y & Cook ME (2001) The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 40, 283-298. (Pubitemid 32547235)
-
(2001)
Progress in Lipid Research
, vol.40
, Issue.4
, pp. 283-298
-
-
Pariza, M.W.1
Park, Y.2
Cook, M.E.3
-
8
-
-
0036195963
-
Trans-10, cis-12 conjugated linoleic acid increases fatty acid oxidation in 3T3-l1 preadipocytes
-
Evans M, Lin X, Odle J, et al. (2002) Trans-10, cis-12 conjugated linoleic acid increases fatty acid oxidation in 3T3-L1 preadipocytes. J Nutr 132, 450-455. (Pubitemid 34208748)
-
(2002)
Journal of Nutrition
, vol.132
, Issue.3
, pp. 450-455
-
-
Evans, M.1
Lin, X.2
Odle, J.3
McIntosh, M.4
-
9
-
-
16244396154
-
Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans
-
Gaullier JM, Halse J, Hoye K, et al. (2005) Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 135, 778-784. (Pubitemid 40464104)
-
(2005)
Journal of Nutrition
, vol.135
, Issue.4
, pp. 778-784
-
-
Gaullier, J.-M.1
Halse, J.2
Hoye, K.3
Kristiansen, K.4
Fagertun, H.5
Vik, H.6
Gudmundsen, O.7
-
10
-
-
34248370966
-
Efficacy of conjugated linoleic acid for reducing fat mass: A meta-analysis in humans
-
Whigham LD, Watras AC & Schoeller DA (2007) Efficacy of conjugated linoleic acid for reducing fat mass: A metaanalysis in humans. Am J Clin Nutr 85, 1203-1211. (Pubitemid 46740460)
-
(2007)
American Journal of Clinical Nutrition
, vol.85
, Issue.5
, pp. 1203-1211
-
-
Whigham, L.D.1
Watras, A.C.2
Schoeller, D.A.3
-
11
-
-
0034858073
-
Trans-10, cis-12, but not cis-9, trans-11, conjugated linoleic acid attenuates lipogenesis in primary cultures of stromal vascular cells from human adipose tissue
-
Brown JM, Halvorsen YD, Lea-Currie YR, et al. (2001) Trans- 10, cis-12, but not cis-9, trans-11, conjugated linoleic acid attenuates lipogenesis in primary cultures of stromal vascular cells from human adipose tissue. J Nutr 131, 2316-2321. (Pubitemid 32851875)
-
(2001)
Journal of Nutrition
, vol.131
, Issue.9
, pp. 2316-2321
-
-
Brown, J.M.1
Halvorsen, Y.D.2
Lea-Currie, Y.R.3
Geigerman, C.4
McIntosh, M.5
-
12
-
-
42949100989
-
The trans-10 cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPARgamma-dependent and PPARgammaindependent mechanisms
-
Miller JR, Siripurkpong P, Hawes J, et al. (2008) The trans-10, cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPARgamma-dependent and PPARgammaindependent mechanisms. J Lipid Res 49, 550-562.
-
(2008)
J. Lipid. Res.
, vol.49
, pp. 550-562
-
-
Miller, J.R.1
Siripurkpong, P.2
Hawes, J.3
-
13
-
-
0032796505
-
Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARα
-
Moya-Camarena SY, Vanden Heuvel JP, Blanchard SG, et al. (1999) Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res 40, 1426-1433. (Pubitemid 29379982)
-
(1999)
Journal of Lipid Research
, vol.40
, Issue.8
, pp. 1426-1433
-
-
Moya-Camarena, S.Y.1
Vanden Heuvel, J.P.2
Blanchard, S.G.3
Leesnitzer, L.A.4
Belury, M.A.5
-
14
-
-
52949085126
-
Effects of fish oil and conjugated linoleic acids on expression of target genes of PPAR alpha and sterol regulatory element-binding proteins in the liver of laying hens
-
Konig B, Spielmann J, Haase K, et al. (2008) Effects of fish oil and conjugated linoleic acids on expression of target genes of PPAR alpha and sterol regulatory element-binding proteins in the liver of laying hens. Br J Nutr 100, 355-363.
-
(2008)
Br. J. Nutr.
, vol.100
, pp. 355-363
-
-
Konig, B.1
Spielmann, J.2
Haase, K.3
-
15
-
-
0030791050
-
Effect of conjugated linoleic acid on body composition in mice
-
DOI 10.1007/s11745-997-0109-x
-
Park Y, Albright KJ, Liu W, et al. (1997) Effect of conjugated linoleic acid on body composition in mice. Lipids 32, 853-858. (Pubitemid 27360392)
-
(1997)
Lipids
, vol.32
, Issue.8
, pp. 853-858
-
-
Park, Y.1
Albright, K.J.2
Liu, W.3
Storkson, J.M.4
Cook, M.E.5
Pariza, M.W.6
-
16
-
-
34249686631
-
Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21
-
DOI 10.1016/j.cmet.2007.05.003, PII S1550413107001301
-
Inagaki T, Dutchak P, Zhao G, et al. (2007) Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 5, 415-425. (Pubitemid 46825496)
-
(2007)
Cell Metabolism
, vol.5
, Issue.6
, pp. 415-425
-
-
Inagaki, T.1
Dutchak, P.2
Zhao, G.3
Ding, X.4
Gautron, L.5
Parameswara, V.6
Li, Y.7
Goetz, R.8
Mohammadi, M.9
Esser, V.10
Elmquist, J.K.11
Gerard, R.D.12
Burgess, S.C.13
Hammer, R.E.14
Mangelsdorf, D.J.15
Kliewer, S.A.16
-
17
-
-
40449120742
-
Conjugated linoleic acid reduces body fat accretion and lipogenic gene expression in neonatal pigs fed low- or high-fat formulas
-
Corl BA, Mathews Oliver SA, Lin X, et al. (2008) Conjugated linoleic acid reduces body fat accretion and lipogenic gene expression in neonatal pigs fed low- or high-fat formulas. J Nutr 138, 449-454. (Pubitemid 351355239)
-
(2008)
Journal of Nutrition
, vol.138
, Issue.3
, pp. 449-454
-
-
Corl, B.A.1
Mathews Oliver, S.A.2
Lin, X.3
-
18
-
-
2942659668
-
Dietary conjugated linoleic acid and body composition
-
Wang Y & Jones PJ (2004) Dietary conjugated linoleic acid and body composition. Am J Clin Nutr 79, 1153S-1158S.
-
(2004)
Am. J. Clin. Nutr.
, vol.79
-
-
Wang, Y.1
Jones, P.J.2
-
19
-
-
36048957846
-
Conjugated linoleic acid (CLA) and obesity
-
DOI 10.1017/S1368980007000687, PII S1368980007000687
-
Silveira MB, Carraro R, Monereo S, et al. (2007) Conjugated linoleic acid (CLA) and obesity. Public Health Nutr 10, 1181-1186. (Pubitemid 350085207)
-
(2007)
Public Health Nutrition
, vol.10
, Issue.10 A
, pp. 1181-1186
-
-
Silveira, M.B.1
Carraro, R.2
Monereo, S.3
Tebar, J.4
-
20
-
-
76749093608
-
Antiobesity mechanisms of action of conjugated linoleic acid
-
Kennedy A, Martinez K, Schmidt S, et al. (2010) Antiobesity mechanisms of action of conjugated linoleic acid. J Nutr Biochem 21, 171-179.
-
(2010)
J. Nutr. Biochem.
, vol.21
, pp. 171-179
-
-
Kennedy, A.1
Martinez, K.2
Schmidt, S.3
-
21
-
-
70349324370
-
Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver
-
Hotta Y, Nakamura H, Konishi M, et al. (2009) Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 150, 4625-4633.
-
(2009)
Endocrinology
, vol.150
, pp. 4625-4633
-
-
Hotta, Y.1
Nakamura, H.2
Konishi, M.3
-
22
-
-
79951713560
-
Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins
-
Tyynismaa H, Raivio T, Hakkarainen A, et al. (2011) Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins. J Clin Endocrinol Metab 96, E351-E355.
-
(2011)
J. Clin. Endocrinol. Metab.
, vol.96
-
-
Tyynismaa, H.1
Raivio, T.2
Hakkarainen, A.3
-
23
-
-
77957359658
-
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
-
Li H, Fang Q, Gao F, et al. (2010) Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol 53, 934-940.
-
(2010)
J. Hepatol.
, vol.53
, pp. 934-940
-
-
Li, H.1
Fang, Q.2
Gao, F.3
-
24
-
-
79956113302
-
Circadian rhythm of circulating fibroblast growth factor 21 FGF21 is related to the diurnal changes in fatty acids in humans
-
Yu H, Xia F, Lam KS, et al. (2011) Circadian rhythm of circulating fibroblast growth factor 21 (FGF21) is related to the diurnal changes in fatty acids in humans. Clin Chem 57, 691-700.
-
(2011)
Clin. Chem.
, vol.57
, pp. 691-700
-
-
Yu, H.1
Xia, F.2
Lam, K.S.3
-
25
-
-
79151469687
-
Lipotoxicity and steatohepatitis in an overfed mouse model for nonalcoholic fatty liver disease
-
Gaemers IC, Stallen JM, Kunne C, et al. (2011) Lipotoxicity and steatohepatitis in an overfed mouse model for nonalcoholic fatty liver disease. Biochim Biophys Acta 1812, 447-458.
-
(2011)
Biochim. Biophys. Acta.
, vol.1812
, pp. 447-458
-
-
Gaemers, I.C.1
Stallen, J.M.2
Kunne, C.3
-
26
-
-
40449089260
-
Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARγ activity in primary cultures of human adipocytes
-
Kennedy A, Chung S, LaPoint K, et al. (2008) Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. J Nutr 138, 455-461. (Pubitemid 351355240)
-
(2008)
Journal of Nutrition
, vol.138
, Issue.3
, pp. 455-461
-
-
Kennedy, A.1
Chung, S.2
LaPoint, K.3
Fabiyi, O.4
McIntosh, M.K.5
-
27
-
-
47949111205
-
Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states
-
Muise ES, Azzolina B, Kuo DW, et al. (2008) Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol Pharmacol 74, 403-412.
-
(2008)
Mol. Pharmacol.
, vol.74
, pp. 403-412
-
-
Muise, E.S.1
Azzolina, B.2
Kuo, D.W.3
|